Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK2A1 | P68400 | 20/20 | 0.60 |
| ▸ | CSNK2A2 | P19784 | 18/20 | 0.60 |
| ▸ | CSNK2B | P67870 | 15/20 | 0.60 |
| ▸ | CSNK2A3 | Q8NEV1 | 7/20 | 0.46 |
| ▸ | CLK2 | P49760 | 1/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.45 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27322142 | 0.90 | CSNK2A1 (0.61) | CSNK2A1CSNK2A2CSNK2BCSNK2A3CLK2 | |
| SCHEMBL30803613 | 0.90 | CSNK2A1 (0.61) | CSNK2A1CSNK2A2CSNK2BCSNK2A3CLK2 | |
| SCHEMBL27322160 | 0.89 | CSNK2A2 (0.61) | CSNK2A1CSNK2A2CSNK2BCSNK2A3CLK2 | |
| SCHEMBL30803645 | 0.89 | CSNK2A2 (0.61) | CSNK2A1CSNK2A2CSNK2BCSNK2A3CLK2 | |
| SCHEMBL25370461 | 0.83 | CSNK2A1 (0.71) | CSNK2A1CSNK2A2CSNK2BCSNK2A3HDAC1 | |
| SCHEMBL25370378 | 0.82 | CSNK2A1 (0.62) | CSNK2A1CSNK2A2CSNK2BCSNK2A3HDAC1 | |
| SCHEMBL29900390 | 0.82 | CSNK2A2 (0.61) | CSNK2A1CSNK2A2CSNK2BCSNK2A3HDAC1 | |
| SCHEMBL25369036 | 0.82 | CSNK2A2 (0.61) | CSNK2A1CSNK2A2CSNK2BCSNK2A3HDAC1 | |
| SCHEMBL30803369 | 0.81 | CSNK2A1 (0.61) | CSNK2A1CSNK2A2CSNK2BCSNK2A3HDAC1 | |
| SCHEMBL26048826 | 0.81 | CSNK2A2 (0.63) | CSNK2A1CSNK2A2CSNK2BCSNK2A3HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024052692-A1 | NOVEL COMPOUNDS AS CK2 INHIBITORS | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2024-03-14 | — | — | WO | disclosed |